001     132663
005     20240229105025.0
024 7 _ |a 10.1002/mrm.26952
|2 doi
024 7 _ |a pmid:29030876
|2 pmid
024 7 _ |a 0740-3194
|2 ISSN
024 7 _ |a 1522-2594
|2 ISSN
024 7 _ |a altmetric:27548470
|2 altmetric
037 _ _ |a DKFZ-2018-00323
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Niesporek, Sebastian
|0 P:(DE-He78)96512bceb234fc9ec15569396cbc3a34
|b 0
|e First author
|u dkfz
245 _ _ |a Reproducibility of CMRO2determination using dynamic17O MRI.
260 _ _ |a New York, NY [u.a.]
|c 2018
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1525333196_1077
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a To assess the reproducibility of17O MRI-based determination of the cerebral metabolic rate of oxygen consumption (CMRO2) in healthy volunteers. To assess the influence of image acquisition and reconstruction parameters on dynamic quantification of functional parameters such as CMRO2.Dynamic17O MRI data were simulated and used to investigate influences of temporal resolution (Δt) and partial volume correction (PVC) on the determination of CMRO2. Three healthy volunteers were examined in two separate examinations. In vivo17O MRI measurements were conducted with a nominal spatial resolution of (7.5 mm)3using a density-adapted radial sequence with golden angle acquisition scheme. In each measurement, 4.0 ± 0.1 L of 70%-enriched17O gas were administered using a rebreathing system. Data were corrected with a PVC algorithm, and CMRO2was determined in gray matter (GM) and white matter (WM) compartments using a three-phase metabolic model (baseline,17O inhalation, decay phase).Comparison with the ground truth of simulations revealed improved CMRO2determination after application of PVC and with Δt ≤ 2:00 min. Evaluation of in vivo data yields to CMRO2,GM = 2.31 ± 0.1 μmol/g/min and to CMRO2,WM = 0.69 ± 0.04 μmol/g/min with coefficients of variation (CoV) of 0.3-5.5% and 4.3-5.0% for intra-volunteer and inter-volunteer data, respectively.This in vivo17O inhalation study demonstrated that the proposed experimental setup enables reproducible determination of CMRO2in healthy volunteers. Magn Reson Med 79:2923-2934, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
536 _ _ |a 315 - Imaging and radiooncology (POF3-315)
|0 G:(DE-HGF)POF3-315
|c POF3-315
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Umathum, Reiner
|0 P:(DE-He78)b8678d0841b587098d787b52c38ba439
|b 1
|u dkfz
700 1 _ |a Lommen, Jonathan
|0 P:(DE-He78)b1993ad043211815ad62d0c3de882b39
|b 2
|u dkfz
700 1 _ |a Behl, Nicolas
|0 P:(DE-He78)596c7f2f2a07a37019b79f94ad8a4190
|b 3
|u dkfz
700 1 _ |a Paech, Daniel
|0 P:(DE-He78)c6e31fb8f19e185e254174554a0cccfc
|b 4
|u dkfz
700 1 _ |a Bachert, Peter
|0 P:(DE-He78)29b2f01310f7022916255ddba2750f9b
|b 5
|u dkfz
700 1 _ |a Ladd, Mark
|0 P:(DE-He78)022611a2317e4de40fd912e0a72293a8
|b 6
|u dkfz
700 1 _ |a Nagel, Armin
|0 P:(DE-He78)054fd7a5195b75b11fbdc5c360276011
|b 7
|e Last author
|u dkfz
773 _ _ |a 10.1002/mrm.26952
|g Vol. 79, no. 6, p. 2923 - 2934
|0 PERI:(DE-600)1493786-4
|n 6
|p 2923 - 2934
|t Magnetic resonance in medicine
|v 79
|y 2018
|x 0740-3194
909 C O |o oai:inrepo02.dkfz.de:132663
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)96512bceb234fc9ec15569396cbc3a34
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)b8678d0841b587098d787b52c38ba439
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)b1993ad043211815ad62d0c3de882b39
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)596c7f2f2a07a37019b79f94ad8a4190
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)c6e31fb8f19e185e254174554a0cccfc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)29b2f01310f7022916255ddba2750f9b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)022611a2317e4de40fd912e0a72293a8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)054fd7a5195b75b11fbdc5c360276011
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-315
|2 G:(DE-HGF)POF3-300
|v Imaging and radiooncology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MAGN RESON MED : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)E020-20160331
|k E020
|l Medizinische Physik in der Radiologie
|x 0
920 1 _ |0 I:(DE-He78)E010-20160331
|k E010
|l Radiologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)E020-20160331
980 _ _ |a I:(DE-He78)E010-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21